Order Article Reprints

Huang C-M, Huang M-Y, Tsai H-L, Huang C-W, Su W-C, Chang T-K, Chen Y-C, Li C-C, Wang J-Y. Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Cancers. 2021; 13(18):4589. https://doi.org/10.3390/cancers13184589

Huang, Chun-Ming, Ming-Yii Huang, Hsiang-Lin Tsai, Ching-Wen Huang, Wei-Chih Su, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, and Jaw-Yuan Wang. 2021. "Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer" Cancers 13, no. 18: 4589. https://doi.org/10.3390/cancers13184589

Huang, C.-M., Huang, M.-Y., Tsai, H.-L., Huang, C.-W., Su, W.-C., Chang, T.-K., Chen, Y.-C., Li, C.-C., & Wang, J.-Y. (2021). Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer. Cancers, 13(18), 4589. https://doi.org/10.3390/cancers13184589